Regression of choroidal metastasis from breast carcinoma following Letrozole therapy

Pradeep Venkatesh; Satpal Garg

doi:10.1111/j.1442-9071.2007.01520.x

Regression of choroidal metastasis from breast carcinoma following Letrozole therapy

Clin Exp Ophthalmol. 2007 Jul;35(5):492-4. doi: 10.1111/j.1442-9071.2007.01520.x.

Authors

Pradeep Venkatesh¹, Satpal Garg

Affiliation

¹ Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

PMID: 17651258
DOI: 10.1111/j.1442-9071.2007.01520.x

Abstract

Metastasis to the choroid from primary tumours elsewhere in the body is not an infrequent occurrence. Management of such metastasis may involve modalities such as radiotherapy, chemotherapy, photocoagulation and surgical resection. The role of hormonal therapy is poorly defined in the management of these tumours. Herein regression of choroidal metastasis from primary breast carcinoma following antihormonal therapy with the antioestrogen drug Letrozole is reported.

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Agents / therapeutic use*
Breast Neoplasms / drug therapy*
Breast Neoplasms / pathology
Choroid Neoplasms / drug therapy*
Choroid Neoplasms / secondary
Estrogen Receptor Modulators / therapeutic use*
Female
Fluorescein Angiography
Humans
Letrozole
Nitriles / therapeutic use*
Remission Induction
Tomography, Optical Coherence
Triazoles / therapeutic use*

Substances

Antineoplastic Agents
Estrogen Receptor Modulators
Nitriles
Triazoles
Letrozole